lomefloxacin, aspartate
Modify Date: 2024-01-08 15:29:17
lomefloxacin, aspartate structure
|
Common Name | lomefloxacin, aspartate | ||
|---|---|---|---|---|
| CAS Number | 211690-33-4 | Molecular Weight | 484.451 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H26F2N4O7 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of lomefloxacin, aspartateLomefloxacin (SC47111A) aspartate is a broad-spectrum quinolone antibacterial agent. Lomefloxacin aspartate can be used for researching respiratory tract infections, genitourinary infections, gastrointestinal infections, ENT infections, etc.[1][2]. |
| Name | (2S)-2-aminobutanedioic acid,1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
|---|---|
| Synonym | More Synonyms |
| Description | Lomefloxacin (SC47111A) aspartate is a broad-spectrum quinolone antibacterial agent. Lomefloxacin aspartate can be used for researching respiratory tract infections, genitourinary infections, gastrointestinal infections, ENT infections, etc.[1][2]. |
|---|---|
| Related Catalog | |
| Target |
MIC90: 0.12 mg/L (Haemophilus influenzae), 0.25 mg/L (Moraxella catarrhalis), 0.06 mg/L (Legionella pneumophila)[1] |
| References |
[2]. Reem I Al-Wabli. Lomefloxacin. Profiles Drug Subst Excip Relat Methodol. 2017;42:193-240. |
| Molecular Formula | C21H26F2N4O7 |
|---|---|
| Molecular Weight | 484.451 |
| Exact Mass | 484.176941 |
| PSA | 175.19000 |
| LogP | 1.76300 |
| Storage condition | -20°C Freezer |
| I06-2220 |
| DM 10 L-Aspartate |
| (S)-2-Aminosuccinic acid 1-ethyl-6,8-difluoro-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid (1:1) |
| 3-Quinolinecarboxylic acid, 1-ethyl-6,8-difluoro-1,4-dihydro-7-(3-methyl-1-piperazinyl)-4-oxo-, compd. with L-aspartic acid (1:1) |
| Lomefloxacin Aspartate |
| 1-Ethyl-6,8-difluoro-7-(3-methyl-1-piperazinyl)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid - L-aspartic acid (1:1) |